Sanjay S. Shukla
2019
In 2019, Sanjay S. Shukla earned a total compensation of $664K as President and Chief Executive Officer at aTYR PHARMA, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,625 |
|---|---|
| Option Awards | $82,400 |
| Salary | $450,000 |
| Stock Awards | $25,860 |
| Other | $10,076 |
| Total | $663,961 |
Shukla received $450K in salary, accounting for 68% of the total pay in 2019.
Shukla also received $95.6K in non-equity incentive plan, $82.4K in option awards, $25.9K in stock awards and $10.1K in other compensation.
Rankings
In 2019, Sanjay S. Shukla's compensation ranked 10,891st out of 13,971 executives tracked by ExecPay. In other words, Shukla earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,891 out of 13,971 | 22nd |
Division Manufacturing | 4,405 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,722 out of 2,200 | 22nd |
Industry group Drugs | 1,476 out of 1,886 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 331 out of 389 | 15th |
Source: SEC filing on April 2, 2020.
Shukla's colleagues
We found two more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2019.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019